| Document Date: 2015-04-28 07:44:05
Open Document File Size: 123,39 KBShare Result on Facebook
City Philadelphia / / Facility Memorial Sloan-Kettering / / IndustryTerm treatment of chronic lymphocytic leukemia / / MedicalCondition Leukemia / inoperable gastrointestinal stromal tumours / advanced gastrointestinal stromal tumor / Gastrointestinal Stromal Tumor / advanced hepatocellular carcinoma / CANCER / Multiple Myeloma / NSCLC / chromosome-positive acute lymphoblastic leukemia / Gastrointestinal Stromal Tumours / chronic lymphocytic leukemia / metastatic clear cell renal cell carcinoma / Hepatocellular Carcinoma / neutropenic fever / neutropenia / patient’s disease / small Cell Lung Cancer / aggressive / high risk disease / acute lymphoblastic leukemia / Colon Cancer / Acute Promyelocytic Leukemia / chronic myelogenous leukemia / chronic phase / Non-Small Cell Lung Cancer / Renal Cell Carcinoma / chronic myeloid leukemia / chemotherapy Myelodysplastic Syndrome / Philadelphia Chromosome Acute Lymphoblastic Leukemia / Cancer Metastases - For / metastatic clear cell renal carcinoma / cytogenetic abnormality transfusion dependent anemia / Colon Cancer Metastases / / MedicalTreatment Chemotherapy / radiotherapy / surgery / induction of remission / / NaturalFeature Edward Island / / Organization PEI Pharmacare Office / / / Position general practitioner / Physician / specialist / / Product FLUDARA / VESANOID / SPRYCEL / GLEEVEC / NEUPOGEN / NEXAVAR / TASIGNA / TACE / XELODA / REVLIMID / Tretinoin / Trisenox / SUTENT / TARCEVA / / ProvinceOrState Prince Edward Island / / Technology alpha / gene expression / Chemotherapy / stem cells / /
SocialTag |
SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS (Filgrastim, Capecitabine, Imatinib, Dasatinib, Erolotinib, Sunitinib, Pazopanib, Fludarabine, Sorafenib, Crizotinib, Tretinoin, Nilotinib, Temozolomid